Study concludes visits conducted at home improves recruitment/retention and speeds trials

In Clinical Development by Freya Smale

global care clinical trialsGlobalCare Clinical Trials, Ltd continues expansion of patient-centric services to over 25 countries across 5 continents. GlobalCare provides selected clinical study visits at patients’ homes, workplace or alternate settings to support phase I-IV trials across a variety of therapeutic areas and genomics research. CEO, Gail Adinamis, states that “our service model provides faster patient recruitment, better protocol compliance and higher retention rates, while decreasing development time. Our model was built on the simple premise that if you make study participation convenience and comfortable, more patients will be willing and able to participate.” Ms. Adinamis founded and pioneered the service model which she introduced over 20 years ago.

GlobalCare centrally manages a network of multilingual, GCP/ICH certified country coordinators who have an in-depth knowledge of local medical practices, country regulations and cultural attitudes. The network is augmented by an extensive pool of over 25,000 qualified local traveling physicians and study nurses across North America, Latin America, Europe and Asia-Pacific.

Reduction in subject recruitment time by over 50% and an increase in subject retention rate of over 95% are among the results that have spurred GlobalCare’s rapid growth. “Oncology, rare diseases, neurologic disorders and infectious diseases are among the therapeutic areas most demanding of these services,” said Ms. Adinamis. “We also support a wide variety of trials requiring pharmacokinetic, safety or specialty labs on a frequent or long term basis,” Adinamis continued.

GlobalCare is a global niche service provider to government agencies and the world’s biotechnology, pharmaceutical and medical device companies engaged in all phases of product development. GlobalCare offers an innovative patient-centric service model that provides selected clinical study visits in the home or alternate setting resulting in faster patient recruitment, better compliance and higher retention rates, helping to expedite time-to-market for life-enhancing products. GlobalCare’s model enables patients to participate in clinical trials regardless of study duration; frequency of visits; disease state; distance to site; and/or family, work or community commitments by conducting study visits in a location convenient to them.

Services include Global Project Management, study drug administration, blood and other biologic sample collection, clinical assessments, patient training and education, device management, source documentation, and data collection. In addition, the company offers central and local out-patient pharmacy services including storage and distribution, compounding and dispensing, cold chain logistics, and sourcing of commercial products and devices.

For more information, please visit, or download this Scope of Service >

GlobalCare will also be joining us at the World Orphan Drug Congress 2014. Join them by clicking here >